These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29657613)

  • 41. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients' productivity losses and informal care costs related to ischemic stroke: a French population-based study.
    Barral M; Rabier H; Termoz A; Serrier H; Colin C; Haesebaert J; Derex L; Nighoghossian N; Schott AM; Viprey M;
    Eur J Neurol; 2021 Feb; 28(2):548-557. PubMed ID: 33047452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct and indirect costs attributable to osteoarthritis in active subjects.
    Rabenda V; Manette C; Lemmens R; Mariani AM; Struvay N; Reginster JY
    J Rheumatol; 2006 Jun; 33(6):1152-8. PubMed ID: 16755664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.
    Bennebroek Evertsz' F; Nieuwkerk PT; Stokkers PC; Ponsioen CY; Bockting CL; Sanderman R; Sprangers MA
    J Crohns Colitis; 2013 Dec; 7(11):890-900. PubMed ID: 23269224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.
    Lublóy Á
    BMC Public Health; 2019 Sep; 19(1):1242. PubMed ID: 31500616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
    Shafer LA; Shaffer S; Witt J; Nugent Z; Bernstein CN
    Inflamm Bowel Dis; 2022 Aug; 28(8):1189-1197. PubMed ID: 34636400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The economics of mesalazine in active ulcerative colitis and maintenance in the Netherlands.
    Connolly MP; Boersma C; Oldenburg B
    Neth J Med; 2012 Aug; 70(6):272-7. PubMed ID: 22859419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Etrolizumab for induction of remission in ulcerative colitis.
    Rosenfeld G; Parker CE; MacDonald JK; Bressler B
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011661. PubMed ID: 26630451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost of illness of medically treated benign prostatic hyperplasia in Hungary.
    Rencz F; Kovács Á; Brodszky V; Gulácsi L; Németh Z; Nagy GJ; Nagy J; Buzogány I; Böszörményi-Nagy G; Majoros A; Nyirády P
    Int Urol Nephrol; 2015 Aug; 47(8):1241-9. PubMed ID: 26093585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study.
    Gisbert JP; Cooper A; Karagiannis D; Hatlebakk J; Agréus L; Jablonowski H; Nuevo J
    Health Qual Life Outcomes; 2009 Oct; 7():90. PubMed ID: 19835583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFα Therapy.
    van der Valk ME; Mangen MJ; Severs M; van der Have M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk C; Vermeijden JR; Siersema PD; Leenders M; Oldenburg B; ;
    J Crohns Colitis; 2015 Nov; 9(11):1016-23. PubMed ID: 26254056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
    Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease.
    Reilly MC; Gerlier L; Brabant Y; Brown M
    Clin Ther; 2008 Feb; 30(2):393-404. PubMed ID: 18343277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial.
    Van Tubergen A; Boonen A; Landewé R; Rutten-Van Mölken M; Van Der Heijde D; Hidding A; Van Der Linden S
    Arthritis Rheum; 2002 Oct; 47(5):459-67. PubMed ID: 12382292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Costs and quality of life of multiple sclerosis in Germany.
    Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population.
    Pilon D; Ding Z; Muser E; Obando C; Voelker J; Manceur AM; Kinkead F; Lafeuille MH; Lefebvre P
    Curr Med Res Opin; 2020 Aug; 36(8):1285-1294. PubMed ID: 32427006
    [No Abstract]   [Full Text] [Related]  

  • 59. Productivity Losses Due to Migraine in Slovenia: An Analysis of Absenteeism and Presenteeism Costs Based on Administrative and Self-Reported Data.
    Lotrič Dolinar A; Žvan B; Došenović Bonča P
    Zdr Varst; 2020 Jun; 59(2):75-82. PubMed ID: 32952706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland.
    Kawalec PP; Malinowski KP
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):667-73. PubMed ID: 26153642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.